FDA OK’s Hemodynamic Monitoring Device

The FDA has granted 510(k) clearance to Retia Medical’s Argos monitor, a hemodynamic monitor that measures an adult patient’s cardiac output in the operating room and ICUs.

The device uses signal processing and algorithms to create a model of the patient’s circulation, giving physicians information that helps them track oxygen delivery and fluid status in high-risk surgeries.

The Argos monitor can directly connect to a vital-sign monitor to reduce costs and remove the need for disposables.